Title: Selective optimization of side activities: another way for drug discovery.
Journal: Journal of medicinal chemistry 20040311
113165-32-5
132866-11-6
187731-34-6
113578-26-0
113317-61-6
113145-69-0
1217703-95-1 | entAtomoxetine-d3,Hydrochloride | AA01E07X | MFCD09839950
1313516-26-5 | (S)-3-((6-Acetylnaphthalen-2-yl)amino)-2-aminopropanoic acid | AA01E0S3 | MFCD22741589
1391054-76-4 | Diclofenamide-13C6 | AA01E1SP | MFCD28138396
873-58-5 | sodium morpholine-4-carbodithioate | AA01E27R | MFCD00715553
16974-44-0 | DeshydroxySotalolHydrochloride | AA01E2MD | MFCD27966027
1883545-47-8 | I-BET151Dihydrochloride | AA01E3EW | MFCD30182237
22852-13-7 | N-Acetylpurinomycin | AA01E3RL | MFCD30182346
403848-09-9 | N-AcetylDorzolamide | AA01E4CD
59917-39-4 | VindesineSulfateSalt | AA01E4QM | MFCD21365110
85815-37-8 | RilmazafoneHydrochloride | AA01E5FD | MFCD00887600